Researcher.Life Logo

The Midwest Quarterly : Impact Factor & More

eISSN: 0026-3451pISSN: 0026-3451

Key Metrics

CiteScore
0.2
SNIP
0.03
Recommended pre-submission checks
Powered by Paperpal by Editage

The Midwest Quarterly Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
Overview
Publisher PITTSBURG STATE UNIV
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year1959
View less

Planning to publish in The Midwest Quarterly ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in The Midwest Quarterly

Early Optic Nerve Head Swelling Rate is Associated with Worsening of Visual Outcomes in Nonarteritic Anterior Ischemic Optic Neuropathy.
  • 18 May 2026
  • Ophthalmology
Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Consensus Statement by the North American Neuro-Ophthalmology Society and the American Academy of Ophthalmology.
  • 14 May 2026
  • Ophthalmology
Intravitreal Bevacizumab Improves Trabeculectomy Survival at 3 Years: Long-term Follow-up from The 'Bevacizumab in Trabeculectomy Study'.
  • 13 May 2026
  • Ophthalmology
Oculomotor Nerve Sheath Dilatation Mimicking Schwannomas.
  • 11 May 2026
  • Ophthalmology
Clobetasol Propionate Ophthalmic Suspension (BYQLOVI®) to Treat Ocular Inflammation and Pain after Uncomplicated Cataract Surgery.
  • 5 May 2026
  • Ophthalmology
Ocular Surface Squamous Neoplasia Masquerading as Viral Keratitis.
  • 1 May 2026
  • Ophthalmology
Early Optic Nerve Head Swelling Rate is Associated with Worsening of Visual Outcomes in Nonarteritic Anterior Ischemic Optic Neuropathy.
  • 18 May 2026
  • Ophthalmology
Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Consensus Statement by the North American Neuro-Ophthalmology Society and the American Academy of Ophthalmology.
  • 14 May 2026
  • Ophthalmology
Intravitreal Bevacizumab Improves Trabeculectomy Survival at 3 Years: Long-term Follow-up from The 'Bevacizumab in Trabeculectomy Study'.
  • 13 May 2026
  • Ophthalmology
Oculomotor Nerve Sheath Dilatation Mimicking Schwannomas.
  • 11 May 2026
  • Ophthalmology
Clobetasol Propionate Ophthalmic Suspension (BYQLOVI®) to Treat Ocular Inflammation and Pain after Uncomplicated Cataract Surgery.
  • 5 May 2026
  • Ophthalmology
Ocular Surface Squamous Neoplasia Masquerading as Viral Keratitis.
  • 1 May 2026
  • Ophthalmology

FAQs on The Midwest Quarterly